Alcon AG | ALC - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
AstraZeneca USD 12.22B 4.04B 2026-06
Bayer EUR 10.04B 168M 2026-06
Essilor EUR 12.52B 568M 2026-06
Fresenius EUR 5.23B 9M 2026-06
Fresenius Medical Care EUR 4.32B 20.7M 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
GRIFOLS EUR 1.55B 94M 2026-06
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.34B 249M 2026-06
Novartis USD 10.2B 912M 2026-06
Philips EUR 3.75B 147M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 9.92B 607M 2026-06
Smith & Nephew USD 2.59B 71M 2026-06
Sonova Holding CHF 1.52B 59.9M 2025-12
UCB EUR 2.96B 196M 2025-12